Frontal lobe volume in patients with Huntington's disease

Neurology

Volumn 50, Issue 1, 1998, Pages 252-258

  Aylward, E H ^a   Anderson, N B ^a   Bylsma, F W ^a   Wagster, M V ^a   Barta, P E ^a   Sherr, M ^a   Feeney, J ^a   Davis, A ^a   Rosenblatt, A ^a   Pearlson, G D ^a   Ross, C A ^a  

^a Department of Neuroscience ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; WHITE MATTER;

EID: 0031950826     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.252     Document Type: Article

References (28)

1. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577.
2. Roos RAC. Neuropathology of Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Vol. 5: Extrapyramidal disorders. Amsterdam: Elsevier Science Publishers 1986:315-326.
3. Brandt J, Strauss ME, Larus J, et al. Clinical correlates of dementia and disability in Huntington's disease. J Clin Neuropsychol 1984;6:401-412.
4. Caine ED, Hunt RD, Weingartner H, Ebert MH. Huntington's dementia: clinical and neuropsychological features. Arch Gen Psychiatry 1978;35:377-384.
5. Stuss DT, Benson DF. The frontal lobes. New York: Raven Press, 1986.
6. Brandt J, Bylsma FW. The dementia of Huntington's disease. In: Parks R, Zec R, Wilson R, eds. Neuropsychology of Alzheimer's disease and other dementias. New York: Oxford University Press, 1993;265-282.
7. Starkstein SE, Brandt J, Folstein S, et al. Neuropsychological and neuroradiological correlates in Huntington's disease. J Neurol Neurosurg Psychiatry 1988;51:1259-1263.
8. Folstein M, Brandt J, Starkstein S. Cognition in Huntington's disease: characteristics and correlates. In: Franks A, Ironside J, Mindham R, Smith R, Spokes E, Winlow W, eds. Function and dysfunction in the basal ganglia. Manchester, England: Manchester University Press, 1990:224-229.
9. Folstein SE, Leigh RR, Parhad IM, Folstein MF. The diagnosis of Huntington's disease. Neurology 1986;36:1279-1283.
10. Stine OC, Pleasant N, Franz ML, et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 1993;2:1547-1549.
11. Brandt J, Bylsma FW, Gross R, et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527-531.
12. Aylward E, Codori A, Barta P, et al. Basal ganglia volume and proximity to onset in presymptomatic, Huntington's disease. Arch Neurol 1996;53:1293-1296.
13. Aylward EH, Li Q, Stine OC, et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997;48:394-399.
14. Aylward EH, Augustine A, Li Q, et al. Measurement of frontal lobe volume on magnetic resonance imaging scans. Psychiatry Res 1997;75:23-30.
15. Barta PE, Dhingra L, Royall R, Schwartz E. Improving stereo-logical estimates for the volume of structures identified in three-dimensional arrays of spatial data. J Neurosci Methods 1997;75:111-118.
16. Aylward EH, Brandt J, Codori A, et al. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828.
17. Starkstein SE, Folstein SE, Brandt J, et al. Brain atrophy in Huntington's disease: a CT-scan study. Neuroradiology 1989; 31:156-159.
18. Masucci EF, Borts FT, Kurtzke JF. CT brainstem abnormalities in the differential diagnosis of Huntington's disease. Comput Med Imaging Graph 1990;14:205-212.
19. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI. Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991;29:68-81.
20. Bruyn GW. Neuropathological changes in Huntington's chorea. In: Barbeau A, Chase TN, Paulson GW, eds. Advances in neurology. Vol 1: Huntington's chorea, 1872-1972. New York: Raven Press, 1973:399-403.
21. De la Monte SM, Vonsattel JP, Richardson EP. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-525.
22. Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 1991;133:257-261.
23. Harris GJ, Pearlson GD, Peyser CE, et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992;31: 69-75.
24. Harris G, Aylward E, Peyser C, et al. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease. Arch Neurol 1996;53:316-324.
25. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40: 922-935.
26. Berent S, Giordani B, Lehtinen S, et al. Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function. Ann Neurol 1988;23:541-546.
27. Kuhl DE, Metter EJ, Riege WH, Markham CH. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease. Ann Neurol 1984;15(suppl):S119-S125.
28. Mangiarini L, Kirupa S, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996;87: 493-506